Biological Information

Background Information:

The calcitonin family of bioactive peptides comprises of calcitonin, amylin, two calcitonin-gene related peptides (CGRP1, and CGRP2) and adrenomedullin. Adrenomedullin is a 52-aa hypotensive peptide. It has structural similarity with CGRP and amylin. ADM is produced in peripheral tissues, adrenal medulla, lung, and kidney. Co-expression of receptor activity modifying protein RAMP2 and RAMP3 with calcitonin receptor-like receptor (CRLR) has been identified respectively as the adrenomedullin receptor 1 (AMR1) designated the CRLR/RAMP2 receptor and the adrenomedullin receptor 2 (AMR2) denoted as the CRLR/RAMP3 receptor. The three known RAMP isoforms (1-3) have been identified as distinct gene products and are required for receptor plasma membrane expression as well as for determination of CRLR receptor phenotype and specificity. Adrenomedullin receptors are coupled to the Gs protein resulting in elevation of intracellular cAMP, Ca2+ mobilization and nitric oxide production. Adrenomedullin receptor agonism may result in hypotension associated with cardiac inotropic activity, angiogenesis and mitogenic activity promoting human malignancies. Adrenomedullin receptor antagonism may find therapeutic use in the treatment of heart disease, cerebral vascular disease, type I diabetes and immune disorder, sepsis and cancer.

No. of Assays on Panel:

2

Assays on Panel:

Family

GPCR

Name

Item

1621

Protein

CLR

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1622

Protein

CLR

Organism

Human

Assay Sub Type

Cell Based

Family:

GPCR

Sub Family:

Calcitonin

Class:

Class B

Protein Name:

CLR

Uniprot Number:

Q16602

Protein Aliases:

Calcitonin receptor-like receptor

Gene Name:

CALCRL

Gene ID:

10203

Gene Aliases:

CGRPR|CRLR

Organism:

Human

Cell Type:

CHO-K1

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Agonist & Antagonist

Detection Method:

HTRF

Testing Information

Incubation:

30 min at RT

Control Activator:

hCGRPalpha (0.3 nM)

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 60 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

16

Turnaround Time

Standard:

15 Business Days

Clinical Relevance

Therapeutic Area:

Inflammation/Allergy

Adverse / Beneficial Action:

CGRP1 receptor agonism may cause or contribute to vasodilation, nociception, gastrointestinal mucous secretion, spasm and inflammation. CGRP1 receptor antagonism may have therapeutic as a spasmolytic, antidiarrheal, antiinflammatory and antinociception.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 373
Item: 1621
Item: 1622